Humanwell Healthcare Group Co

Humanwell Healthcare Group Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Humanwell Healthcare Group Co (600079.SS) as of Oct 31, 2026 is 96.27 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 85.98 % — a change of 11.96% (higher).

FCF Conversion

96.27 %

YoY

11.96%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Humanwell Healthcare Group Co is 2025 96.27 % . FCF Conversion Rate (FCF/EBITDA) of Humanwell Healthcare Group Co was 2024 85.98 % . It decreases by 11.96% higher compared to the previous year.

The Humanwell Healthcare Group Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
31.03 CNY
Jan 1, 2019
144.40 CNY
Jan 1, 2020
88.55 CNY
Jan 1, 2021
36.12 CNY
Jan 1, 2022
-27.06 CNY
Jan 1, 2023
0.42 CNY
Jan 1, 2024
85.98 CNY
Jan 1, 2025
96.27 CNY
The Humanwell Healthcare Group Co FCF Conversion history
YEARFCF ConversionYoY
96.27 %+11.96%
85.98 %+20,451.40%
0.42 %-101.55%
-27.06 %-174.92%
36.12 %-59.21%
88.55 %-38.68%
144.40 %+365.34%
31.03 %-137.86%
-81.96 %-4.95%
-86.24 %+8.97%
-79.14 %-9.34%
-87.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

FCF Conversion Rate (FCF/EBITDA) of Humanwell Healthcare Group Co is 96.27 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Humanwell Healthcare Group Co changed from 85.98 % to 96.27 %, representing a 11.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Humanwell Healthcare Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Humanwell Healthcare Group Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Humanwell Healthcare Group Co